Podcast
ADC Manufacturing Demand Outpaces Capacity in US Market
“Twenty years ago, who knew that ADCs and next-generation bioconjugates were going to be so exciting, so successful?” Campbell Bunce, Chief Scientific Officer at Abzena, reflects on the strategic positioning that has placed his company at the forefront of one
15 December 2025
